Elkem ASA Resets Strategy After Mixed Earnings Call

Elkem ASA ((NO:ELK)) has held its Q4 earnings call. Read on for the main highlights of the call.

Elkem ASA’s latest earnings call painted a cautiously optimistic picture for investors, balancing weak current earnings and market conditions with a bold strategic reset. Management acknowledged sharp year‑on‑year declines in revenue, EBITDA and EPS, as well as safety and trade headwinds, but argued that a transformational divestment, equity raise and cost actions set up a leaner, better‑funded business for recovery.

Strategic divestment of Silicones to Bluestar

Elkem’s headline move is the sale of the majority of its Silicones division to China National Bluestar via a share redemption of Bluestar’s 338 million Elkem shares, with no cash changing hands. The deal, expected to close around end‑April or May pending an extraordinary general meeting and lender approvals, will leave Elkem as a more focused Silicon Products and Carbon Solutions pure‑play with lower capital intensity and clearer capital allocation.

Underwritten equity and balance sheet actions

To reinforce the balance sheet post‑transaction, Elkem has secured pre‑commitments and underwriting from a group of institutional investors for a NOK 1.5 billion equity raise. On a pro forma basis, management expects net interest‑bearing debt of about NOK 8.3 billion and leverage of roughly 3.6x EBITDA after the issue, positioning the group for refinancing of key credit facilities but implying dilution for existing minority shareholders.

Q4 operational cash generation

Despite weak markets, Elkem’s Q4 operating cash flow reached NOK 829 million, a clear improvement on prior quarters. The company attributed this to lower capital expenditure and favorable working capital movements, underscoring that cash discipline is starting to offset cyclical pressure on earnings.

Solid Q4 EBITDA and margins despite weak markets

Group EBITDA in Q4 came in at NOK 890 million with a 12% margin, evidencing resilience in a difficult pricing environment. Excluding Silicones, the business generated about NOK 4.0 billion in operating income and NOK 485 million in EBITDA at a similar 12% margin, suggesting the remaining core units can still operate profitably at trough‑like price levels.

Silicones division profitability improvement

The Silicones unit, which is being sold, delivered roughly NOK 400 million in EBITDA in Q4, up around 6% year on year despite the tough backdrop. Management highlighted cost improvements and better pricing late in the year in Asia Pacific as the main drivers, showing that the asset is being exited from a position of strengthening earnings, not distress.

Cost and efficiency improvements across divisions

Across Silicon Products and Carbon Solutions, Elkem continues to execute on raw material savings and operational efficiency programs that partly offset weaker demand and lower sales prices. These initiatives are central to management’s plan to restore margins and support the long‑term EBITDA margin target once markets normalize.

Favorable ferrosilicon price impact from EU safeguard measures

The company is seeing a positive price effect from EU safeguard measures on ferrosilicon, with reference prices in the EU up about 20% since implementation. This price support provides a rare tailwind for Silicon Products and helps cushion the blow from broader commodity weakness and soft end‑market demand.

Strong historical performance and clear outlook targets

Management emphasized Elkem’s track record, noting compound annual operating income growth of roughly 5% and a 16% EBITDA margin since 2020, with even stronger metrics if Silicones is excluded. Looking ahead, the company is targeting more than 10% top‑line growth in 2026 versus 2025 for the remaining business, alongside structurally lower annual investments of around NOK 1.0 billion.

YoY decline in revenue and EBITDA

The cyclical downturn remains evident in the headline numbers, as Q4 operating income dropped 14% year on year to NOK 7.3 billion. Group EBITDA declined 24% to NOK 890 million, driven by historically low prices for key products such as silicon and ferrosilicon, reminding investors that the recovery story still starts from a low base.

Sharp profitability drops in Silicon Products and Carbon Solutions

Silicon Products’ EBITDA slid to NOK 294 million in Q4, down about 53% year on year, even though sales volumes rose 8%, highlighting how depressed prices are. Carbon Solutions fared little better, with EBITDA falling 38% to NOK 174 million as sales volumes dropped 11%, underscoring broad demand weakness in core industrial end‑markets.

Negative EPS and earnings impact from Silicones

At the bottom line, Elkem reported a Q4 loss with EPS of negative NOK 0.21 and year‑to‑date EPS of minus NOK 1.05. Management stressed that Silicones was a major drag and that excluding this division, full‑year 2025 EPS would have been positive at NOK 0.61, reinforcing the strategic rationale for the divestment.

Trade barriers and tariffs creating uncertainty

The company faces a complex trade environment, with EU safeguards limiting quotas to roughly 70–75% of historic ferrosilicon sales and the U.S. imposing multiple duties on silicon metal. Combined with earlier tariffs, Elkem now faces an effective tariff exposure of about 40% on U.S. silicon exports, creating material uncertainty around volumes, pricing and optimal asset deployment.

Market demand weakness weighing on volumes and prices

End‑market demand remains soft, with global steel production down around 3% year on year in Q4 and Chinese output off about 9%. Construction and automotive markets are particularly subdued in Europe and the U.S., keeping pressure on both volumes and pricing for Elkem’s core products and delaying any broad‑based demand recovery.

Equity dilution and no dividend for 2025

For shareholders, the restructuring comes with a cost, as the board has proposed not to pay a dividend for 2025 in light of the share redemption tied to the Silicones sale. The underwritten NOK 1.5 billion equity raise also means dilution for minority investors, underscoring that balance sheet repair is taking precedence over near‑term cash returns.

Transitional and refinancing risks

Elkem’s post‑transaction leverage and the need to refinance its main credit facilities introduce execution risk in the coming quarters. Management plans further balance sheet measures and will rely on approvals and creditor waivers to reach its target credit profile, making successful refinancing a key catalyst for the equity story.

Serious safety incident impacting ESG

The call also addressed a tragic safety incident at the Silicones R&D site in Sanfo near Lyon on 22 December, where four employees were injured and two lost their lives. Investigations are ongoing, and management acknowledged that the event is a significant setback for the group’s ESG profile and a stark reminder of the operational risks in its industrial activities.

Forward‑looking guidance and outlook

Management guided for Q1 results broadly in line with Q4, with similar operating income and EBITDA margins, while noting a temporary capacity reduction in Norway that will weigh on EBITDA but improve cash flow. They expect slightly higher volumes in Carbon Solutions, better silicone pricing in China, more than 10% underlying top‑line growth in 2026 versus 2025 for the remaining business and annual investments around NOK 1 billion, with the Silicones sale and equity raise jointly leaving pro forma leverage near 3.6x and a long‑term EBITDA margin ambition of 15–20%.

Elkem’s earnings call ultimately set out a story of short‑term pain in service of long‑term focus and financial resilience, with weak current profitability offset by strong cash generation and decisive portfolio reshaping. Investors must weigh dilution, refinancing and market risks against the prospect of a simpler, better‑capitalized silicon and carbon materials player targeting renewed growth and margin expansion into 2026 and beyond.